Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1→3)-β-D-glucan antigens

被引:0
作者
A. Kędzierska
P. Kochan
A. Pietrzyk
J. Kędzierska
机构
[1] Jagiellonian University Medical College,Department of Clinical Microbiology, Chair of Clinical Immunology and Transplantology, Polish
[2] Jagiellonian University Medical College,American Institute of Paediatrics
[3] University Hospital,Chair of Microbiology
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2007年 / 26卷
关键词
Aspergillosis; Invasive Aspergillosis; Invasive Candidiasis; Invasive Pulmonary Aspergillosis; Fusariosis;
D O I
暂无
中图分类号
学科分类号
摘要
Early diagnosis of fungal infections and the implementation of appropriate treatment represent major issues for clinicians, nowadays. Histopathological demonstration of microorganisms in tissue specimens or growth of fungal agents in culture media is still considered the “gold standard”, but obtaining such specimens may be difficult. Several groups have investigated serological assays for cell wall elements unique to fungal organisms in serum or other body fluids to improve diagnostics in patients with haematological malignancies or undergoing haematopoietic stem-cell transplantation. In this review we have concentrated on the currently available assays allowing for detection of highly immunogenic components of fungal cell wall: galactomannan, mannan, and also (1→3)-β-D-glucan. Rapid serological tests appear to be useful for screening high-risk haematological patients, since they allow for the early diagnosis of invasive fungal infections, including infections with the most common pathogens such as Aspergillus and Candida. Based on current literature, factors increasing the probability of obtaining false-positive or false-negative results detected by each test were also analysed and tabulated.
引用
收藏
页码:755 / 766
页数:11
相关论文
共 453 条
[51]  
Ghannoum MA(1996)Detection of the Respiration 63 78-83
[52]  
Glauser M(1997) antigen mannan in cerebrospinal fluid specimens from patients suspected of having J Med Vet Mycol 35 371-374
[53]  
Herbrecht R(2003) meningitis Kansenshogaku Zasshi 77 227-234
[54]  
Kauffman CA(1997)β-D-Glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and yelodysplastic syndrome Clin Lab Anal 11 73-77
[55]  
Kohno S(2006)Multicenter clinical evaluation of (1→3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 42 1054-1056
[56]  
Martino P(1999)Relation between stage of endogenous fungal endophthalmitis and prognosis FEMS Immunol Med Microbiol 4 411-420
[57]  
Meunier F(1995)Plasma (1→3)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis Lancet 345 17-20
[58]  
Mori T(2003)The performance of (1, 3)-beta-D-glucan and Clin Diagn Lab Immunol 10 882-885
[59]  
Pfaller MA(2003) galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases Microbiol Immunol 47 173-182
[60]  
Rex JH(2004)Circulating β (1–3) glucan and immunoglobulin G subclass antibodies to Nippon Ishinkin Gakkai Zasshi 45 217-221